HMWO.L vs. DRDR.L
HMWO.L (HSBC MSCI World UCITS ETF) and DRDR.L (iShares Healthcare Innovation UCITS ETF USD (Acc)) are both exchange-traded funds - HMWO.L is a Global Equities fund tracking the MSCI World Index, while DRDR.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD. Both are passively managed. Over the past 5 years, HMWO.L returned 12.20%/yr vs -0.78%/yr for DRDR.L. A 0.71 correlation means they provide meaningful diversification when combined. HMWO.L charges 0.15%/yr vs 0.40%/yr for DRDR.L.
Performance
HMWO.L vs. DRDR.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HMWO.L achieves a 10.00% return, which is significantly higher than DRDR.L's 6.68% return.
HMWO.L
- 1D
- -0.54%
- 1M
- -0.20%
- 6M
- 8.77%
- YTD
- 10.00%
- 1Y
- 21.22%
- 3Y*
- 17.85%
- 5Y*
- 12.20%
- 10Y*
- 12.94%
DRDR.L
- 1D
- -0.17%
- 1M
- 6.96%
- 6M
- 2.11%
- YTD
- 6.68%
- 1Y
- 25.03%
- 3Y*
- 7.44%
- 5Y*
- -0.78%
- 10Y*
- —
HMWO.L vs. DRDR.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HMWO.L HSBC MSCI World UCITS ETF | 10.00% | 12.63% | 21.17% | 17.80% | -8.47% | 23.98% | 12.48% | 23.41% | -3.60% | 12.05% |
DRDR.L iShares Healthcare Innovation UCITS ETF USD (Acc) | 6.68% | 10.25% | 2.62% | -2.51% | -14.93% | -5.21% | 48.69% | 8.88% | 2.12% | 23.69% |
Correlation
The correlation between HMWO.L and DRDR.L is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.64 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2016 | 0.71 |
Over the past year, the correlation between HMWO.L and DRDR.L has dropped to 0.46 - well below their long-term average of 0.71, suggesting their price drivers have been diverging.
HMWO.L vs. DRDR.L - Sectors Allocation Comparison
Sectors
HMWO.L
DRDR.L
Technology
Financial Services
Industrials
Healthcare
Consumer Cyclical
-
Communication Services
-
Consumer Defensive
Energy
-
Basic Materials
Utilities
-
Real Estate
Technology
HMWO.L
DRDR.L
Financial Services
HMWO.L
DRDR.L
Industrials
HMWO.L
DRDR.L
Healthcare
HMWO.L
DRDR.L
Consumer Cyclical
HMWO.L
DRDR.L
-
Communication Services
HMWO.L
DRDR.L
-
Consumer Defensive
HMWO.L
DRDR.L
Energy
HMWO.L
DRDR.L
-
Basic Materials
HMWO.L
DRDR.L
Utilities
HMWO.L
DRDR.L
-
Real Estate
HMWO.L
DRDR.L
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HMWO.L vs. DRDR.L — Risk / Return Rank
HMWO.L
DRDR.L
HMWO.L vs. DRDR.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for HSBC MSCI World UCITS ETF (HMWO.L) and iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HMWO.L | DRDR.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.42 | ||
| Sortino ratioReturn per unit of downside risk | +0.47 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.27 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 3.25 | 1.99 | +1.25 |
| Martin ratioReturn relative to average drawdown | 12.65 | 4.87 | +7.78 |
Loading charts...
Drawdowns
HMWO.L vs. DRDR.L - Drawdown Comparison
The maximum HMWO.L drawdown since its inception was -44.90%, which is greater than DRDR.L's maximum drawdown of -38.49%. Use the drawdown chart below to compare losses from any high point for HMWO.L and DRDR.L.
Loading charts...
Drawdown Indicators
| HMWO.L | DRDR.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.90% | -38.49% | -6.41% |
Max Drawdown (1Y)Largest decline over 1 year | -6.51% | -12.51% | +6.00% |
Max Drawdown (3Y)Largest decline over 3 years | -18.80% | -22.88% | +4.08% |
Max Drawdown (5Y)Largest decline over 5 years | -18.80% | -35.81% | +17.01% |
Max Drawdown (10Y)Largest decline over 10 years | -25.48% | — | — |
Current DrawdownCurrent decline from peak | -0.99% | -12.21% | +11.22% |
Average DrawdownAverage peak-to-trough decline | -9.77% | -17.39% | +7.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.67% | 5.13% | -3.46% |
Volatility
HMWO.L vs. DRDR.L - Volatility Comparison
The current volatility for HSBC MSCI World UCITS ETF (HMWO.L) is 2.57%, while iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) has a volatility of 5.03%. This indicates that HMWO.L experiences smaller price fluctuations and is considered to be less risky than DRDR.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HMWO.L | DRDR.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 2.57% | 5.03% | -2.46% |
Volatility (6M)Calculated over the trailing 6-month period | 7.85% | 11.99% | -4.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 10.63% | 15.94% | -5.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.31% | 22.14% | -8.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.38% | 22.54% | -8.16% |
HMWO.L vs. DRDR.L - Expense Ratio Comparison
HMWO.L has a 0.15% expense ratio, which is lower than DRDR.L's 0.40% expense ratio.
Dividends
HMWO.L vs. DRDR.L - Dividend Comparison
HMWO.L's dividend yield for the trailing twelve months is around 1.17%, while DRDR.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DRDR.L iShares Healthcare Innovation UCITS ETF USD (Acc) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HMWO.L HSBC MSCI World UCITS ETF | 1.17% | 1.26% | 1.41% | 1.60% | 1.75% | 1.27% | 1.55% | 1.97% | 2.11% | 1.91% | 1.84% | 1.86% |
Frequently Asked Questions
HMWO.L and DRDR.L have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, HMWO.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
HMWO.L is cheaper with a 0.15% expense ratio, compared with 0.40% for DRDR.L.
HMWO.L is categorized as Global Equities, while DRDR.L is Health & Biotech Equities. HMWO.L tracks MSCI World Index, while DRDR.L tracks MSCI World/Health Care NR USD. They also come from different issuers: HSBC and iShares. Their fees differ too: 0.15% for HMWO.L and 0.40% for DRDR.L.
Find the right allocation for HMWO.L and DRDR.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer